Meeting
2023 ASCO Annual Meeting
Investigation of cancer predisposition in Fanconi anemia heterozygotes: A DiscovEHR cohort population study.
Authors
Joseph Deng
National Cancer Institute, Rockville, MD
Joseph Deng , Burak Altintas , Jeremy Haley , Jung Kim , David J. Carey , Douglas R Stewart , Lisa J McReynolds
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10589)
DOI
10.1200/JCO.2023.41.16_suppl.10589
Abstract #
10589
Poster Bd #
222
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer.
First Author: Li yuan Guo
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh